» Articles » PMID: 33652118

Circadian Clock Disruption Suppresses PDL1 Intraepithelial B Cells in Experimental Colitis and Colitis-Associated Colorectal Cancer

Overview
Specialty Gastroenterology
Date 2021 Mar 2
PMID 33652118
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: The circadian clock is crucial for physiological homeostasis including gut homeostasis. Disorder of the circadian clock may contribute to many diseases including inflammatory bowel disease (IBD). However, the role and the mechanisms of circadian clock involvement in IBD still are unclear.

Methods: Disorder of the circadian clock including chronic social jet lag and circadian clock gene deficiency mice (Bmal1, and Per1Per2) were established. Dextran sulfate sodium (DSS) and/or azoxymethane were used to induce mouse models of colitis and its associated colorectal cancer. Flow cytometry, immunohistochemistry, immunofluorescence, Western blot, and reverse-transcription quantitative polymerase chain reaction were used to analyze the characteristics of immune cells and their related molecules.

Results: Mice with disorders of the circadian clock including chronic social jet lag and circadian clock gene deficiency were susceptible to colitis. Functionally, regulatory B (Breg) cells highly expressing Programmed cell death 1 ligand 1 (PDL1) in intestinal intraepithelial lymphocytes (IELs) helped to alleviate the severity of colitis after DSS treatment and was dysregulated in DSS-treated Bmal1 mice. Notably, interleukin 33 in the intestinal microenvironment was key for Bmal1-regulated PDL1 Breg cells and interleukin 33 was a target of Bmal1 transcriptionally. Dysregulated PDL1 B cells induced cell death of activated CD4 T cells in DSS-treated Bmal1 mice. Consequently, circadian clock disorder was characterized as decreased numbers of Breg PDL1 cells in IELs and dysfunction of CD4 T cells promoted colitis-associated colorectal cancer (CRC) in mice. In clinical samples from CRC patients, low expression of Bmal1 gene in paracancerous tissues and center area of tumor was associated closely with a poorer prognosis of CRC patients.

Conclusions: Our study uncovers the importance of the circadian clock regulating PDL1 Breg cells of IELs in IBD and IBD-associated CRC.

Citing Articles

Unveiling the novel role of circadian rhythms in sepsis and septic shock: unexplored implications for chronotherapy.

Ramsay S, Nenke M, Meyer E, Torpy D, Young R Front Endocrinol (Lausanne). 2025; 16:1508848.

PMID: 39968295 PMC: 11832378. DOI: 10.3389/fendo.2025.1508848.


Natural Compounds for Preventing Age-Related Diseases and Cancers.

Ki M, Youn S, Kim D, Pack S Int J Mol Sci. 2024; 25(14).

PMID: 39062777 PMC: 11276798. DOI: 10.3390/ijms25147530.


Circadian rhythm disruption-mediated downregulation of Bmal1 exacerbates DSS-induced colitis by impairing intestinal barrier.

Zhang Z, Li W, Han X, Tian D, Yan W, Liu M Front Immunol. 2024; 15:1402395.

PMID: 38895112 PMC: 11183104. DOI: 10.3389/fimmu.2024.1402395.


Morning light treatment for inflammatory bowel disease: a clinical trial.

Cohen-Mekelburg S, Goldstein C, Rizvydeen M, Fayyaz Z, Patel P, Berinstein J BMC Gastroenterol. 2024; 24(1):179.

PMID: 38778264 PMC: 11110384. DOI: 10.1186/s12876-024-03263-2.


The role of circadian clock in regulating cell functions: implications for diseases.

Lin Y, He L, Cai Y, Wang X, Wang S, Li F MedComm (2020). 2024; 5(3):e504.

PMID: 38469551 PMC: 10925886. DOI: 10.1002/mco2.504.


References
1.
Kobori A, Yagi Y, Imaeda H, Ban H, Bamba S, Tsujikawa T . Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. J Gastroenterol. 2010; 45(10):999-1007. DOI: 10.1007/s00535-010-0245-1. View

2.
Mauri C, Bosma A . Immune regulatory function of B cells. Annu Rev Immunol. 2012; 30:221-41. DOI: 10.1146/annurev-immunol-020711-074934. View

3.
Seregin S, Golovchenko N, Schaf B, Chen J, Pudlo N, Mitchell J . NLRP6 Protects Il10 Mice from Colitis by Limiting Colonization of Akkermansia muciniphila. Cell Rep. 2017; 19(4):733-745. PMC: 5528001. DOI: 10.1016/j.celrep.2017.03.080. View

4.
Bamias G, Nyce M, De La Rue S, Cominelli F . New concepts in the pathophysiology of inflammatory bowel disease. Ann Intern Med. 2005; 143(12):895-904. DOI: 10.7326/0003-4819-143-12-200512200-00007. View

5.
Ranjbaran Z, Keefer L, Farhadi A, Stepanski E, Sedghi S, Keshavarzian A . Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol. 2007; 22(11):1748-53. DOI: 10.1111/j.1440-1746.2006.04820.x. View